The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Diagnos Inc closed at $0.11.

Although unchanged over the last five days, shares are down 12.00% for the last year to date. This security has outperformed the S&P TSX by 168.02% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.03
Updated October 18 3:13 PM EDT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Total other revenue--------
Total revenue0210
Gross profit0110
Total cost of revenue0101
Total operating expense1411
Selling / general / administrative1311
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-1-20-1
Interest income (expense), net non-operating0-100
Gain (loss) on sale of assets--------
Income before tax-1-30-1
Income after tax-1-30-1
Income tax, total--------
Net income0-30-1
Total adjustments to net income--------
Net income before extra. items-1-30-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-30-1
Inc. avail. to common incl. extra. items0-30-1
Diluted net income0-30-1
Dilution adjustment0000
Diluted weighted average shares164124140121
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.020.00-0.01
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.01-0.020.00-0.01